Dr. Don Curtis Deno, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 409 137th Ln Nw, Andover, MN 55304 Phone: 763-754-0442 |
News Archive
Genentech, a member of the Roche Group, today announced results from OCEANS, a Phase III study evaluating Avastin (bevacizumab) in combination with chemotherapy followed by the continued use of Avastin alone in women with previously treated (recurrent) platinum-sensitive ovarian cancer.
An international stroke study found that standard and intensive blood pressure treatments were equally effective in the emergency treatment of acute intracerebral hemorrhage, a type of stroke caused by bleeding into the brain.
Persistent depression symptoms may be associated with significantly greater declines in cognitive performance in older patients with coronary artery disease who underwent cardiac catheterization, according to a study published in the March issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, today announced that the U.S. Patent and Trademark Office has issued a patent on methods for treating patients with bucindolol based on genetic targeting and focused on a specific genotype - homozygous wildtype for Deletion 322-325 in the alpha-2C adrenergic receptor.
The Obesity Medicine Association today announced the immediate availability of the 2020 OMA Obesity Algorithm, with new information for clinicians including obesity myths, polycystic ovary syndrome, obesity and psychiatric disease, ketogenic diet, as well as many other updates.
› Verified 7 days ago